Columbus Hill Capital Management L.P. Has $30.82 Million Holdings in Humana Inc. (NYSE:HUM)

Columbus Hill Capital Management L.P. reduced its stake in Humana Inc. (NYSE:HUM) by 48.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,490 shares of the insurance provider’s stock after selling 77,954 shares during the period. Humana comprises approximately 6.3% of Columbus Hill Capital Management L.P.’s investment portfolio, making the stock its 3rd largest position. Columbus Hill Capital Management L.P. owned 0.07% of Humana worth $30,822,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares in the last quarter. Hantz Financial Services Inc. bought a new position in shares of Humana in the 2nd quarter valued at $35,000. Family Firm Inc. acquired a new stake in shares of Humana during the 2nd quarter valued at $37,000. Carolinas Wealth Consulting LLC grew its position in Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after acquiring an additional 74 shares during the last quarter. Finally, Hollencrest Capital Management acquired a new position in Humana in the 2nd quarter worth about $40,000. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Baird R W raised Humana to a “hold” rating in a research note on Thursday, May 30th. Oppenheimer upped their price target on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. Cantor Fitzgerald reiterated a “neutral” rating and set a $395.00 price target on shares of Humana in a report on Friday. Deutsche Bank Aktiengesellschaft increased their price objective on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada lifted their target price on Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, September 5th. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $398.70.

Humana Price Performance

Shares of HUM opened at $310.41 on Friday. The business’s fifty day moving average is $357.71 and its 200 day moving average is $345.63. Humana Inc. has a 12-month low of $298.61 and a 12-month high of $530.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock has a market cap of $37.40 billion, a P/E ratio of 19.33, a P/E/G ratio of 2.56 and a beta of 0.50.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $8.94 earnings per share. Sell-side analysts anticipate that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Monday, September 30th. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.